Editor’s Note: This contributed material was composed by the Virginia Economic Development Partnership and was approved for publication by Location Advancement.
Virginia closed 2025 with a lot of momentum in the life sciences area, with multi-billion-dollar investments from Eli Lilly and Company and AstraZeneca picking the Commonwealth for their latest expansions and Merck & Co. beginning on its brand-new production facility at its existing Elkton website. The statements highlight 2 of Virginia’s greatest strengths in the life sciences market– workforce and site advancement– and speak to a growing consensus that the Commonwealth can provide what business need, rapidly.
Related Research
“We wish to have the ability to deal with partners in the allowing sector that understand us, that we can rely on and move fast,” AstraZeneca CEO Pascal Soriot said. “Virginia’s group is incredibly fast. We as a business constantly state ‘AstraZeneca speed’– there’s competitors and we require to move fast. We have actually discovered the world of Virginia speed. They move so quickly.”
What appears from the outdoors as unexpected success is the outcome of a technique years in the making. Virginia has actually invested decades lining up education, workforce, research study and development, websites, and logistics to the needs of a market defined by accuracy, scale, and speed. Today, Virginia provides executives a quickly deployable, end-to-end platform to produce the next generation of medications– and a proof of idea that its economic advancement and allowing model works.
Virginia’s team is extremely quick. We as a company constantly say ‘AstraZeneca speed’– there’s competition and we require to move quick. We’ve discovered the world of Virginia speed. They move so quickly.
Pascal Soriot, CEO, AstraZeneca
Virginia’s instructional excellence is well established, having been ranked No. 1 in education for the previous three successive years and six times overall by CNBC. Virginia’s K-12 system, institution of higher learnings, and labor force advancement programs make sure companies have access to a highly experienced workforce. Flagship organizations like Virginia Commonwealth University (including the Medicines for All Institute), the University of Virginia (with the Paul and Diane Manning Institute of Biotechnology), and Virginia Tech (and its Fralin Biomedical Research Institute at VTC, related to the Virginia Tech Carilion School of Medication) are nationally acknowledged for informing engineers and scientists while advancing medical research study.
The Virginia Skill Accelerator Program, ranked as the No. 1 tailored workforce training program in the United States by Company Facilities the last 3 years, is a bottom line in Virginia’s labor force pitch to prospective business. The program, created by VEDP in partnership with the Virginia Community College System and other college partners, provides first-rate training and recruitment solutions that are completely tailored to a provided company’s requirements. All program services are supplied at no cost to qualified new and broadening companies as an incentive for task creation. Lilly, AstraZeneca, and Merck are all using Talent Accelerator services to staff their brand-new centers.
AstraZeneca also took advantage of another VEDP program helping draw in companies to the Commonwealth: the Virginia Organization Ready Sites Program (VBRSP), which determines and examines the preparedness of potential commercial websites. The program assists to establish the websites and acquire permits and approvals to produce a smoother building procedure. The VBRSP assists Virginia enhance business’ speed to market, and its preparation efforts are targeted at getting brand-new facilities up and running as efficiently as possible.
Worldwide market leaders are confirming the Commonwealth’s model. The new investments by AstraZeneca, Lilly, and Merck affirm Virginia’s abilities and will strengthen Virginia’s momentum in attracting and retaining talent. The ripple effect produces more opportunity for trainees, more option for business, and a much deeper community for innovation in Virginia.